Texas Biotech, Synthelabo deal

The companies signed an additional agreement under which TXB will supply to Synthelabo data from its Novastan clinical trials. Novastan, ( argatroban injection) a small molecule thrombin inhibitor, is being studied in HIT/HITTS (heparin-induced thrombocytopenia/heparin-induced thrombocytopenia and thrombosis syndrome). ...